Details of the Drug
General Information of Drug (ID: DMI87UE)
| Drug Name |
Ac-RYYRIK-NH2
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Ac-RYYRIK-NH2; 200959-48-4; CHEMBL437723; Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH(2); acetyl-Arg-Tyr-Tyr-Arg-Ile-Lys-NH(2); Ac-RYYRIK-NH; BDBM85192; BDBM50190305; ZINC169289387; AKOS024456481; CA-1321; CAS_200959-48-4
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 4 | Molecular Weight (mw) | 939.1 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -1.6 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 30 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 14 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 12 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||
References


